Designed by CHAIRONE
-
AbClon Inc. #1401 285, Digital-ro, Guro-gu, Seoul, Republic of Korea
T. +82-2109-1294
F. +82-2109-1296
E. abclon@abclon.com
AbClon’s strong foundations and innovative platforms will help drive the future of
personalized medicine and safeguard the health and hopes of families.
| 제목 | First AT101 research paper published in Molecular Oncology("Molecular Oncology"지 앱클론 논문 게재) | |||||
| 첨부파일 | - | 날짜 | 2014-09-26 | 조회 | 645 | |
|
앱클론㈜에서 제출한 “Combination of novel HER2 targeting antibody 1E11 with trastuzumab shows synergistic antitumor activity in HER2 positive gastric cancer”의 논문이 Molecular Oncology(Impact factor: 5.935)지에 게재 결정되었습니다. 항체의약품 개발의 선두주자 앱클론(주)가 될 수 있도록 더욱 노력하겠습니다. |
||||||